Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Cancer Clinical Trials
Contact Name Hematology and Oncology Clinical Trials
Contact Phone (312) 942-8312
Contact E-mail clinical_trials@rush.edu

For information about most clinical trials in cancer, please see our special cancer clinical trials database. Other open trials may be listed below. If you have questions about clinical trials in cancer, call Laurie Smith, director of research, Division of Hematology/Oncology, at (312) 942-8312.

Included in this section:

Brachytherapy for Early Stage Breast Cancer: Clinical study to evaluate the safety and performance of the Axxent electronic brachytherapy system in women with resected, early stage breast cancer

Breast Cancer & Microbiota Study: A study to examine the differences in the composition of colonic microbiota and their metabolic activity in patients with and without breast cancer.

Educational Approaches to Weight Management in Breast Cancer Survivors: Information on clinical trials at Rush University Medical Center in Chicago that measure the effectiveness of educational approaches to weight management in breast cancer survivors

Esophageal Cancer and Oncogel: Information about the use of OncoGel to treat esophageal cancer.

Favorable-Risk Prostate Cancer Study: RTOG 0415: A phase III randomized study of hypofractionated 3D-CRT/IMRT versus conventionally fractionated 3D-CRT/IMRT in patients with favorable-risk prostate cancer

Intermediate Risk Prostatic Cancer Study: RTOG 0232: A phase III study comparing combined external beam radiation and transperineal interstitial prmanent brachytherapy with brachytherapy alone for selected patients with intermediate risk prostatic cancer

Locally Advanced Rectal Cancer: Randomized phase II trial of neoadjuvant combined modality therapy for locally advanced rectal cancer

Prostate Cancer Study: Phase 3, double blind trial, using investigational product in asymptomatic subjects with Gleason sum equal to or lesser than 7, metastatic androgen independent prostatic adenocarcinoma

Prostate Carcinoma Study: Helical tomotherapy treatment of dominant intraprostatic lesions in patients with prostate carcinoma utilizing magnetic resonance imaging and spectroscopic guidance

Reduced Pain in Pediatric Patients Study: A pilot study of the role of acupuncture to reduce pain in pediatric patients



Promotional Information

Clinical Trials Home
Cancer Clinical Trials
Brachytherapy for Early Stage Breast Cancer
Breast Cancer & Microbiota Study
Esophageal Cancer and Oncogel
Favorable-Risk Prostate Cancer Study
Intermediate Risk Prostatic Cancer Study
Prostate Cancer Study
Prostate Carcinoma Study
Rectal Cancer Study
Reduced Pain in Pediatric Patients Study
Weight Management in Breast Cancer Survivors

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612